Mayo Clinic College of Medicine and Science
Rochester, Minnesota, United States
Eric L. Matteson, M.D., M.P.H., FACP, MACR, is emeritus John F. Finn Professor of Medicine and Emeritus Chair, Division of Rheumatology at Mayo Clinic, Rochester, Minnesota, U.S.A., with joint appointment in the Division of Epidemiology in the Department of Health Sciences Research.
Dr. Matteson is a native of Nebraska, and received his B.A. degree from the University of Nebraska. He received the M.D. from the Friedrich-Alexander University, Erlangen-Nürnberg. Subsequently, he completed residency in internal medicine in the Michigan State University system and a fellowship at the University of Michigan and Mayo Clinic, and received his M.P.H. in Epidemiology from the University of North Carolina, Chapel Hill.
Dr. Matteson’s clinical and research interests are in the fields of vasculitis and inflammatory arthritis, and medical history. He has authored/coauthored over 500 original scientific publications and over 60 book chapters and several books on these topics. His research agenda has included investigation into the epidemiology of these diseases and their clinical disease expression and impact on patients who suffer from them, and clinical trials of novel agents. These studies have included epidemiology, healthcare utilization and mortality of rheumatoid arthritis, vasculitis, polymyalgia rheumatica, Sjögren’s syndrome, gout, sarcoidosis and other diseases. A major focus of the research has been clinical and translational work in rheumatoid lung disease.
14T03: Global Summit: Welcome and Keynote Address
Thursday, November 14, 2024
8:00 AM – 9:00 AM Eastern Time
No financial relationships with ineligible companies to disclose
Global Summit: Welcome Address
Thursday, November 14, 2024
8:00 AM – 8:05 AM Eastern Time
Disclosure(s): American College of Rheumatology: Committee member (Ongoing); Amgen: DSMB (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Horizon Therapeutics: Advisor or Review Panel Member (Ongoing); NIH/NIAMS: Advisor or Review Panel Member (Ongoing); UpToDate: Royalties (Ongoing)
14T15: Global Summit: Challenges to the Global Rheumatology Workforce Shortage
Thursday, November 14, 2024
3:20 PM – 4:20 PM Eastern Time
No financial relationships with ineligible companies to disclose
14T17: Global Summit: Closing Remarks
Thursday, November 14, 2024
4:20 PM – 4:30 PM Eastern Time
No financial relationships with ineligible companies to disclose
Monday, November 18, 2024
3:00 PM – 4:00 PM Eastern Time
Disclosure(s): American College of Rheumatology: Committee member (Ongoing); Amgen: DSMB (Ongoing); Boehringer-Ingelheim: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Horizon Therapeutics: Advisor or Review Panel Member (Ongoing); NIH/NIAMS: Advisor or Review Panel Member (Ongoing); UpToDate: Royalties (Ongoing)